Libmeldy यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

libmeldy

orchard therapeutics (netherlands) bv - atidarsagene autotemcel - leukodystrophy, metachromatic - ostali lijekovi protiv živčanog sustava - libmeldy is indicated for the treatment of metachromatic leukodystrophy (mld) characterized by biallelic mutations in the arysulfatase a (arsa) gene leading to a reduction of the arsa enzymatic activity:in children with late infantile or early juvenile forms, without clinical manifestations of the disease,in children with the early juvenile form, with early clinical manifestations of the disease, who still  have the ability to walk independently and before the onset of cognitive decline.

LAXADIN 5 mg/1 tableta gastrorezistentna tableta बोस्निया और हर्ज़ेगोविना - क्रोएशियाई - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

laxadin 5 mg/1 tableta gastrorezistentna tableta

pliva d.o.o.sarajevo - Бисакодил - gastrorezistentna tableta - 5 mg/1 tableta - 1 gastrorezistentna tableta sadrži: 5 mg bisakodila

KEYTRUDA 25 mg/1 mL koncentrat za rastvor za infuziju बोस्निया और हर्ज़ेगोविना - क्रोएशियाई - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

keytruda 25 mg/1 ml koncentrat za rastvor za infuziju

merck sharp & dohme bh d.o.o. - pembrolizumab - koncentrat za rastvor za infuziju - 25 mg/1 ml - 1 bočica sa 4 ml koncentrata za rastvor za infuziju sadrži: 100 mg pembrolizumaba

Ebvallo यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

ebvallo

pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.

DULCOLAX 5 mg/1 tableta obložena tableta बोस्निया और हर्ज़ेगोविना - क्रोएशियाई - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

dulcolax 5 mg/1 tableta obložena tableta

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - Бисакодил - obložena tableta - 5 mg/1 tableta - 1 obložena tableta sadrži: 5 mg bisakodila

DULCOLAX 10 mg/1 supozitorija čepić बोस्निया और हर्ज़ेगोविना - क्रोएशियाई - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

dulcolax 10 mg/1 supozitorija čepić

hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - Бисакодил - čepić - 10 mg/1 supozitorija - 1 čepić sadrži: 10 mg bisakodila

Vanflyta यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

vanflyta

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, mieloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.